Literature DB >> 16757314

Characterization of AND-34 function and signaling.

Kyriacos Felekkis1, Lawrence A Quilliam, Adam Lerner.   

Abstract

AND-34 is a member of a novel family of proteins (NSP1, NSP2, and NSP3) that have an amino-terminal SH2 domain but bind by a carboxy-terminal GEF (Cdc25)-like domain to the carboxy-terminus of the focal adhesion adapter protein p130Cas. Direct GEF activity of AND-34 toward Ras subfamily members has not been demonstrated with purified protein. Overexpression of AND-34 in epithelial breast cancer cells leads to activation of Rac and Cdc42 by a PI3K-dependent mechanism. This chapter will describe the techniques we used to examine AND-34-induced Rac, Cdc42, Akt, and PAK1 activation in human breast cancer cell lines and in murine lymphoid cell lines. In addition, we summarize techniques used to determine that AND-34 overexpression does not activate R-Ras in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757314     DOI: 10.1016/S0076-6879(05)07006-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  6 in total

1.  BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.

Authors:  Pierre Vanden Borre; Richard I Near; Anthony Makkinje; Gustavo Mostoslavsky; Adam Lerner
Journal:  Cell Signal       Date:  2011-01-22       Impact factor: 4.315

2.  Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).

Authors:  Anthony Makkinje; Pierre Vanden Borre; Richard I Near; Prayag S Patel; Adam Lerner
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

3.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

Review 4.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

Review 5.  Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.

Authors:  Mahendra Singh; Lauren Cowell; Sachiko Seo; Geraldine O'Neill; Erica Golemis
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

6.  NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.

Authors:  Peter D Mace; Yann Wallez; Małgorzata K Dobaczewska; Jeongeun J Lee; Howard Robinson; Elena B Pasquale; Stefan J Riedl
Journal:  Nat Struct Mol Biol       Date:  2011-11-13       Impact factor: 15.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.